Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John O Larkin

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Irish Journal of Medical Science|November 9, 2023
Prognostic value of pre-operative mean corpuscular volume (MCV) in colorectal cancerPoorya Shokuhi, Niall J O'Sullivan, Hugo C Temperley, et al.
The American Surgeon|November 16, 2023
Radiomics; Contemporary Applications in the Management of Anal Cancer; A Systematic ReviewHugo C Temperley, Niall J O'Sullivan, Caitlin Waters, et al.
Cancers|March 14, 2026
Circulating Tumour DNA After Neoadjuvant Therapy in Non-Metastatic Colon Cancer: A Systematic Review and Implications for Surgical Decision-MakingMahmoud M Salama, Charles Eddershaw, Hugo C Temperley, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2022
Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related deathPhilip D Mc Entee, Poorya Shokuhi, Ailin C Rogers, et al.
BMC Cancer|October 3, 2020
Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumorsSusan A Kennedy, Maria E Morrissey, Margaret R Dunne, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
The Optimal Approach to Surgical Management of Goblet Cell Carcinoid of the Appendix: A Systematic ReviewMahmoud M Salama, Maeve A O'Neill, Éanna J Ryan, et al.
International Journal of Molecular Sciences|April 13, 2024
Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic ReviewHugo C Temperley, Timothy Fannon, Niall J O'Sullivan, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Factors Influencing Outcomes and Survival in Anal CancerHugo C Temperley, Benjamin M Mac Curtain, Niall J O'Sullivan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 29, 2025
Immunotherapy for downstaging of locally advanced mismatch repair deficient colorectal cancer: A prospective institutional case seriesMaeve A O'Neill, Emily C Harrold, Charles Gillham, et al.
The British Journal of Radiology|April 18, 2025
MRI-based radiomics nomogram to predict complete response to definitive chemoradiation in patients with anal cancerHugo C Temperley, Fariba Tohidinezhad, Niall J O'Sullivan, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Irish Journal of Medical Science|November 9, 2023
Prognostic value of pre-operative mean corpuscular volume (MCV) in colorectal cancerPoorya Shokuhi, Niall J O'Sullivan, Hugo C Temperley, et al.
The American Surgeon|November 16, 2023
Radiomics; Contemporary Applications in the Management of Anal Cancer; A Systematic ReviewHugo C Temperley, Niall J O'Sullivan, Caitlin Waters, et al.
Cancers|March 14, 2026
Circulating Tumour DNA After Neoadjuvant Therapy in Non-Metastatic Colon Cancer: A Systematic Review and Implications for Surgical Decision-MakingMahmoud M Salama, Charles Eddershaw, Hugo C Temperley, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2022
Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related deathPhilip D Mc Entee, Poorya Shokuhi, Ailin C Rogers, et al.
BMC Cancer|October 3, 2020
Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumorsSusan A Kennedy, Maria E Morrissey, Margaret R Dunne, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
The Optimal Approach to Surgical Management of Goblet Cell Carcinoid of the Appendix: A Systematic ReviewMahmoud M Salama, Maeve A O'Neill, Éanna J Ryan, et al.
International Journal of Molecular Sciences|April 13, 2024
Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic ReviewHugo C Temperley, Timothy Fannon, Niall J O'Sullivan, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Factors Influencing Outcomes and Survival in Anal CancerHugo C Temperley, Benjamin M Mac Curtain, Niall J O'Sullivan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 29, 2025
Immunotherapy for downstaging of locally advanced mismatch repair deficient colorectal cancer: A prospective institutional case seriesMaeve A O'Neill, Emily C Harrold, Charles Gillham, et al.
The British Journal of Radiology|April 18, 2025
MRI-based radiomics nomogram to predict complete response to definitive chemoradiation in patients with anal cancerHugo C Temperley, Fariba Tohidinezhad, Niall J O'Sullivan, et al.
Pageof 5